BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nandwana V, Nandwana NK, Das Y, Saito M, Panda T, Das S, Almaguel F, Hosmane NS, Das BC. The Role of Microbiome in Brain Development and Neurodegenerative Diseases. Molecules 2022;27:3402. [PMID: 35684340 DOI: 10.3390/molecules27113402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mansour SR, Moustafa MAA, Saad BM, Hamed R, Moustafa AA. Impact of diet on human gut microbiome and disease risk. New Microbes New Infect 2021;41:100845. [PMID: 34035924 DOI: 10.1016/j.nmni.2021.100845] [Reference Citation Analysis]
3 Yu X, Zhou G, Shao B, Zhou H, Xu C, Yan F, Wang L, Chen G, Li J, Fu X. Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice. Front Microbiol 2021;12:647304. [PMID: 34025607 DOI: 10.3389/fmicb.2021.647304] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou X, Guo Q, Guo M, Li B, Peng W, Wang D, Ming D, Zheng B. Nanoarmour-shielded single-cell factory for bacteriotherapy of Parkinson's disease. J Control Release 2021;338:742-53. [PMID: 34517041 DOI: 10.1016/j.jconrel.2021.09.009] [Reference Citation Analysis]
5 Pereira TMC, Côco LZ, Ton AMM, Meyrelles SS, Campos-Toimil M, Campagnaro BP, Vasquez EC. The Emerging Scenario of the Gut-Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases. Antioxidants (Basel) 2021;10:1845. [PMID: 34829716 DOI: 10.3390/antiox10111845] [Reference Citation Analysis]
6 Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-zamora A, Mai V, Vedam-mai V. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci 2022;13:782082. [DOI: 10.3389/fnagi.2021.782082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
7 Jena R, Jain R, Muralidharan S, Yanamala VL, Zubair Z, Kantamaneni K, Jalla K, Renzu M, Alfonso M. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease. Cureus 2021;13:e19035. [PMID: 34853754 DOI: 10.7759/cureus.19035] [Reference Citation Analysis]
8 Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models. Mol Med Rep 2022;25:91. [PMID: 35039876 DOI: 10.3892/mmr.2022.12607] [Reference Citation Analysis]
9 Li XX, Zhang F. Targeting TREM2 for Parkinson's Disease: Where to Go? Front Immunol 2021;12:795036. [PMID: 35003116 DOI: 10.3389/fimmu.2021.795036] [Reference Citation Analysis]
10 Anis E, Xie A, Brundin L, Brundin P. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease. Trends Endocrinol Metab 2021:S1043-2760(21)00268-X. [PMID: 34949514 DOI: 10.1016/j.tem.2021.11.005] [Reference Citation Analysis]
11 Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, Li XF, Gao BL. Association of Parkinson's Disease With Microbes and Microbiological Therapy. Front Cell Infect Microbiol 2021;11:619354. [PMID: 33763383 DOI: 10.3389/fcimb.2021.619354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]